Epidemiology of Biofilm Producing Acinetobacter baumannii Nosocomial Isolates from a Tertiary Care Hospital in Egypt: A Cross-Sectional Study

References

• Wong D, Nielsen TB, Bonomo RA, et al. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30:409–430.27974412
   PubMed Web of Science ®Google Scholar
• Bahador A, Farshadzadeh Z, Raoofian R, et al. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation. Ann Clin Microbiol Antimicrob. 2018;17(1):24–35. doi:10.1186/s12941-018-0277-629859115
   PubMed Web of Science ®Google Scholar
• Zeighami H, Valadkhani F, Shapouri R, et al. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis. 2019;19(1):629–637. doi:10.1186/s12879-019-4272-031315572
   PubMed Web of Science ®Google Scholar
• Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007;13(1):97–103. doi:10.3201/eid1301.06071617370521
   PubMed Web of Science ®Google Scholar
• Weber DJ, Rutala WA, Miller MB, et al. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38(Suppl 5):S25–33. doi:10.1016/j.ajic.2010.04.19620569853
   PubMed Web of Science ®Google Scholar
• World Health Organization. Media centre. WHO publishes list of bacteria for which new antibiotics are urgently needed; 2017. Available from: http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/. Accessed 25, 2021.
   Google Scholar
• Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 2017;7:55.28348979
   PubMed Web of Science ®Google Scholar
• Bardbari AM, Arabestani MR, Karami M, et al. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog. 2017;108:122–128. doi:10.1016/j.micpath.2017.04.03928457900
   PubMed Web of Science ®Google Scholar
• Vila-Farres Z, Parra-Millan R, Sanchez-Encinales V, et al. Combating virulence of gram-negative bacilli by ompA inhibition. Sci Rep. 2017;7(1):14683. doi:10.1038/s41598-017-14972-y29089624
   PubMed Web of Science ®Google Scholar
• Greene C, Vadlamudi G, Newton D, et al. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control. 2016;44(5):e65–71. doi:10.1016/j.ajic.2015.12.01226851196
   PubMed Web of Science ®Google Scholar
• Jahangiria S, Malekzadegana Y, Motamedifara M, et al. Virulence genes profile and biofilm formation ability of Acinetobacter baumannii strains isolated from inpatients of a tertiary care hospital in southwest of Iran. Gene Rep. 2019;17:100481. doi:10.1016/j.genrep.2019.100481
   Web of Science ®Google Scholar
• Thummeepak R, Kongthai P, Leungtongkam U, et al. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Int Microbiol. 2016;19(2):121–129. doi:10.2436/20.1501.01.27027845499
   PubMed Web of Science ®Google Scholar
• Yang CH, Su PW, Moi S, et al. Biofilm formation in Acinetobacter baumannii: genotype-phenotype correlation. Molecules. 2019;24(10):E1849. doi:10.3390/molecules2410184931091746
   PubMed Web of Science ®Google Scholar
• Sung JY. Molecular characterization and antimicrobial susceptibility of biofilm-forming Acinetobacter baumannii clinical isolates from Daejeon, Korea. Korean J Clin Lab Sci. 2018;50(2):100–109. doi:10.15324/kjcls.2018.50.2.100
   Google Scholar
• Salehi B, Goudarzi H, Nikmanesh B, et al. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Infect Chemother. 2018;24(7):515–523. doi:10.1016/j.jiac.2018.02.00929555392
   PubMed Web of Science ®Google Scholar
• Smani Y, Fabrega A, Roca I, et al. Role of ompA in the multidrug resistance phenotype of Acinetobacter baumannii. Antimicrob Agents Chemother. 2014;58(3):1806–1808. doi:10.1128/AAC.02101-1324379205
   PubMed Web of Science ®Google Scholar
• STROBE checklist, version 4; 2007. Available from: http://www.strobe-statement.org/index.php?id=available-checklists. Accessed 1022, 2018.
   Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.00218538699
   PubMed Web of Science ®Google Scholar
• Carrol KC, Pfaller MA, Landry ML, et al. Manual of Clinical Microbiology Handbook. 12 ed. Washington, DC: ASM Press; 2019.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. Wayne, PA: CLSI; 2018.
   Google Scholar
• Pfizer Inc. (Wyeth Pharmaceuticals). Tygacil® product insert. Philadelphia, PA; 2016. Available from: http://labeling.pfizer.com/showlabeling.aspx?id=491&pagename=tygacil_fly. Accessed 25, 2021.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Monfared AM, Rezaei A, Poursina F, et al. Detection of genes involved in biofilm formation in MDR and XDR Acinetobacter baumannii isolated from human clinical specimens in Isfahan, Iran. Arch Clin Infect Dis. 2019;14(2):e85766. doi:10.5812/archcid.96531
   Web of Science ®Google Scholar
• Eichenberger EM, Thaden JT. Epidemiology and mechanisms of resistance of extensively resistant gram-negative bacteria. Antibiotics (Basel). 2019;8(2):E37. doi:10.3390/antibiotics802003730959901
   PubMed Web of Science ®Google Scholar
• Duartea A, Ferreiraa S, Almeidaa S, et al. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability. Comp Immunol Microbiol Infect Dis. 2016;45:29–33. doi:10.1016/j.cimid.2016.02.00227012918
   PubMed Web of Science ®Google Scholar
• Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–1301. doi:10.1017/ice.2016.17427573805
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2017. Sona, Sweden: European Center for Disease Prevention. Available from: https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017. Accessed 48, 2019.
   Google Scholar
• Hsu LY, Apisarnthanarak A, Khan E, et al. Carbapenem-resistant Acinetobacter baumannii and enterobacteriaceae in south and southeast Asia. Clin Microbiol Rev. 2017;30(1):1–22. doi:10.1128/CMR.00042-1627795305
   PubMed Web of Science ®Google Scholar
• Rodriguez CH, Nastro M, Famiglietti A. Carbapenemases in Acinetobacter baumannii. Review of their dissemination in Latin America. Rev Argent Microbiol. 2018;50(3):327–333. doi:10.1016/j.ram.2017.10.00629548732
   PubMed Web of Science ®Google Scholar
• Babapour E, Haddadi A, Mirnejad R, et al. Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pac J Trop Biomed. 2016;6(6):528–533. doi:10.1016/j.apjtb.2016.04.006
   Web of Science ®Google Scholar
• Wang L, Zhou K, Chen W, et al. Epidemiology and risk factors for nosocomial infection in the respiratory intensive care unit of a teaching hospital in China: a prospective surveillance during 2013 and 2015. BMC Infect Dis. 2019;19(1):145–153. doi:10.1186/s12879-019-3772-230755175
   PubMed Web of Science ®Google Scholar